Heterogeneity among methicillin-resistant Staphylococcus aureus from Italian pig finishing holdings

Veterinary Microbiology
A BattistiF M Aarestrup

Abstract

A survey for methicillin-resistant Staphylococcus aureus (MRSA) in finishing pig holdings was carried out in Italy in 2008. MRSA isolates were characterised by spa-, MLST-, SCCmec- and antimicrobial susceptibility typing. A prevalence of 38% (45/118, 95% CI 29.4-46.9%) positive holdings was observed. Eleven different spa-types were found among 102 MRSA isolates, clustering in lineages associated with farm animals (ST398, ST9, ST(CC)97 in 36 holdings) and humans (ST1, 7 holdings). Nine (7.6%) holdings were positive for two, three or four different and unrelated spa-types in various combinations. ST398 was the most prevalent lineage (33 positive holdings). The most prevalent spa-type was t899 (ST398), detected in 22 positive holdings. Three novel spa-types (t4794 of ST9; t4795 of ST97; t4838 of ST398) were detected. Ten holdings were positive for spa-type t1730, that proved to be a new single-locus variant of ST97, within the CC97 (ST1476). The most prevalent SCCmec was Type V (79 isolates), while Type IVb was found in 10 isolates. None of the isolates was positive for Panton-Valentine Leukocidin, while most of the t127 and t1730 isolates, one t4794, one t4795, and one t2922 were positive for LukE-LukD genes. All 64 antimicrobial...Continue Reading

References

Sep 24, 2004·Veterinary Microbiology·E van DuijkerenA C Fluit
Mar 11, 2005·Emerging Infectious Diseases·J S WeeseD E Low
Jul 28, 2005·The Journal of Antimicrobial Chemotherapy·Alan P JohnsonGeorgia Duckworth
Mar 21, 2007·Veterinary Microbiology·A J de NeelingX W Huijsdens
Jun 8, 2007·Emerging Infectious Diseases·Eva Juhász-KaszanyitzkyJaap A Wagenaar
Nov 8, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M W H WulfA Voss
Feb 9, 2008·Emerging Infectious Diseases·Inge van LooJan Kluytmans
Nov 26, 2008·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Christiane CunyChristian Stanek
May 1, 2009·Emerging Infectious Diseases·Ruud H DeurenbergEllen E Stobberingh
Oct 17, 2009·Veterinary Microbiology·H HasmanF M Aarestrup

❮ Previous
Next ❯

Citations

May 8, 2014·BioMed Research International·Jhalka KadariyaDipendra Thapaliya
Mar 8, 2011·Applied and Environmental Microbiology·M A ArgudínB Guerra
Oct 12, 2010·Vector Borne and Zoonotic Diseases·Tara C Smith, Nicole Pearson
Mar 15, 2011·Vector Borne and Zoonotic Diseases·Tara C SmithAnne E Dressler
Mar 31, 2011·The Journal of Antimicrobial Chemotherapy·Alessia FrancoAntonio Battisti
Nov 18, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Florence CrombéPatrick Butaye
Jan 15, 2015·International Journal of Environmental Research and Public Health·Ana MorcilloAngeles Arias
May 30, 2012·Comparative Immunology, Microbiology and Infectious Diseases·Ya Ping LoChin Cheng Chou
Mar 6, 2012·Veterinary Microbiology·Anika FrieseUwe Roesler
Nov 25, 2011·Veterinary Microbiology·M Concepción PorreroFrank M Aarestrup
Mar 10, 2015·Enfermedades infecciosas y microbiología clínica·María González-DomínguezFrancisco Javier Castillo
Jan 19, 2012·Letters in Applied Microbiology·M C PorreroL Domínguez
Nov 13, 2012·Veterinary Microbiology·Stefan MoneckeSonia Cortez de Jäckel
Apr 24, 2013·International Journal of Medical Microbiology : IJMM·Christiane CunyWolfgang Witte
Jan 17, 2015·International Journal of Antimicrobial Agents·Yu-Yu Chuang, Yhu-Chering Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.